https://news.medxy.ai/zh/telehealth-stroke-recovery/Medxy AIzh2026-10-25T05:54:51-07:00远程医疗与可穿戴技术助力卒中后身体活动提升：一项可行性随机对照试验 https://news.medxy.ai/ja/telehealth-wearables-post-stroke-activity/Medxy AIja2026-10-25T05:54:32-07:00テレヘルスとウェアラブル技術で脳卒中後の身体活動を高める：実現可能性ランダム化比較試験 https://news.medxy.ai/vi/post-stroke-physical-activity/Medxy AIvi2026-10-25T05:54:03-07:00Tăng cường hoạt động thể chất sau đột quỵ bằng telehealth và công nghệ đeo: kết quả từ một thử nghiệm ngẫu nhiên có đối chứng khả thi https://news.medxy.ai/enhancing-post-stroke-physical-activity-through-telehealth-and-wearable-technology-a-feasibility-randomised-controlled-trial/Medxy AIen2026-10-25T05:53:36-07:00Enhancing Post-Stroke Physical Activity Through Telehealth and Wearable Technology: A Feasibility Randomised Controlled Trial https://news.medxy.ai/zh/advancing-dental-education/Medxy AIzh2026-10-25T05:52:58-07:00推进牙科教育：加拿大牙科学校缺损复合树脂修复体的修补与更换 https://news.medxy.ai/ja/canadian-dental-restoration-repair/Medxy AIja2026-10-25T05:52:28-07:00カナダ歯科教育の新潮流：不良コンポジットレジン修復物は修理か、交換か https://news.medxy.ai/vi/advancing-dental-education-2/Medxy AIvi2026-10-25T05:51:53-07:00Nâng tầm giáo dục nha khoa: Sửa chữa hay thay thế phục hồi composite khiếm khuyết tại các trường nha khoa Canada https://news.medxy.ai/advancing-dental-education-repair-versus-replacement-of-defective-composite-restorations-in-canadian-dental-schools/Medxy AIen2026-10-25T05:51:20-07:00Advancing Dental Education: Repair Versus Replacement of Defective Composite Restorations in Canadian Dental Schools https://news.medxy.ai/zh/yellow-fever-vaccine-dose-safety-immunogenicity/Medxy AIzh2026-10-25T05:50:34-07:00幼儿17DD黄热病疫苗分剂量接种的免疫原性与安全性：乌干达Ⅳ期随机试验及更广泛证据 https://news.medxy.ai/ja/yellow-fever-vaccine-trial/Medxy AIja2026-10-25T05:50:00-07:00幼児における17DD黄熱ワクチン分割接種の免疫原性と安全性：ウガンダ第4相無作為化試験とその位置づけ https://news.medxy.ai/vi/fractional-yellow-fever-vaccine-uganda/Medxy AIvi2026-10-25T05:49:22-07:00Vắc xin sốt vàng 17DD liều phân đoạn ở trẻ nhỏ: Bằng chứng từ thử nghiệm ngẫu nhiên pha 4 tại Uganda và bối cảnh mở rộng https://news.medxy.ai/immunogenicity-and-safety-of-fractional-17dd-yellow-fever-vaccine-doses-in-young-children-evidence-from-a-phase-4-randomised-trial-in-uganda-and-broader-context/Medxy AIen2026-10-25T05:48:50-07:00Immunogenicity and Safety of Fractional 17DD Yellow Fever Vaccine Doses in Young Children: Evidence from a Phase 4 Randomised Trial in Uganda and Broader Context https://news.medxy.ai/zh/pediatric-ventilation-feedback/Medxy AIzh2026-10-25T05:47:48-07:00实时反馈设备助力院前儿科通气质量提升：一项随机研究的启示 https://news.medxy.ai/ja/improving-pediatric-ventilation/Medxy AIja2026-10-25T05:47:20-07:00リアルタイムフィードバック装置で高める前病院小児換気の質：無作為化研究からの示唆 https://news.medxy.ai/vi/pediatric-ventilation-feedback-2/Medxy AIvi2026-10-25T05:46:42-07:00Nâng cao chất lượng thông khí nhi khoa trước bệnh viện bằng thiết bị phản hồi thời gian thực: Những phát hiện từ một nghiên cứu ngẫu nhiên https://news.medxy.ai/enhancing-prehospital-pediatric-ventilation-quality-with-real-time-feedback-devices-insights-from-a-randomized-study/Medxy AIen2026-10-25T05:46:17-07:00Enhancing Prehospital Pediatric Ventilation Quality with Real-Time Feedback Devices: Insights from a Randomized Study https://news.medxy.ai/zh/nerandomilast-pulmonary-fibrosis/Medxy AIzh2026-10-25T05:45:39-07:00nerandomilast有望减缓自身免疫性进行性肺纤维化：FIBRONEER-ILD试验带来新证据 https://news.medxy.ai/ja/nerandomilast-promising-results-in-autoimmune-ild/Medxy AIja2026-10-25T05:45:16-07:00自己免疫疾患関連の進行性肺線維症に対するnerandomilastに期待：FIBRONEER-ILD試験から見えた有望な結果 https://news.medxy.ai/vi/nerandomilast-slows-autoimmune-pulmonary-fibrosis/Medxy AIvi2026-10-25T05:44:52-07:00Nerandomilast cho thấy triển vọng làm chậm xơ phổi tiến triển trong bệnh tự miễn: Góc nhìn từ thử nghiệm FIBRONEER-ILD https://news.medxy.ai/nerandomilast-shows-promise-in-slowing-progressive-pulmonary-fibrosis-in-autoimmune-disease-insights-from-the-fibroneer-ild-trial/Medxy AIen2026-10-25T05:44:28-07:00Nerandomilast Shows Promise in Slowing Progressive Pulmonary Fibrosis in Autoimmune Disease: Insights from the FIBRONEER-ILD Trial https://news.medxy.ai/zh/long-term-proton-pump-inhibitors-after-lung-transplantation/Medxy AIzh2026-10-25T05:43:46-07:00肺移植后长期使用质子泵抑制剂：几乎人人都在用，但20年随访未见明确临床获益 https://news.medxy.ai/ja/long-term-ppi-after-lung-transplantation/Medxy AIja2026-10-25T05:43:19-07:00肺移植後の長期プロトンポンプ阻害薬使用：20年間でほぼ全例に及ぶも、臨床転帰の明確な改善は示されず https://news.medxy.ai/vi/long-term-proton-pump-inhibitors-lung-transplantation/Medxy AIvi2026-10-25T05:42:50-07:00Dùng thuốc ức chế bơm proton dài hạn sau ghép phổi: Gần như phổ biến tuyệt đối nhưng không thấy lợi ích rõ ràng trên kết cục lâm sàng trong hai thập kỷ https://news.medxy.ai/long-term-proton-pump-inhibitor-use-post-lung-transplantation-near-universal-but-no-clear-benefit-on-clinical-outcomes-over-two-decades/Medxy AIen2026-10-25T05:42:27-07:00Long-Term Proton Pump Inhibitor Use Post-Lung Transplantation: Near-Universal but No Clear Benefit on Clinical Outcomes Over Two Decades https://news.medxy.ai/zh/ivarmacitinib-palmoplantar-pustulosis/Medxy AIzh2026-10-25T05:41:40-07:00Ivarmacitinib 在掌跖脓疱病中展现快速且令人鼓舞的疗效与免疫调节作用：多中心临床试验启示 https://news.medxy.ai/ja/ivarmacitinib-pustulosis-palmaris-et-plantaris/Medxy AIja2026-10-25T05:41:17-07:00手掌足底膿疱症に対するIvarmacitinib：多施設試験が示した迅速な有効性と免疫リモデリングの可能性 https://news.medxy.ai/vi/ivarmacitinib-pustular-psoriasis/Medxy AIvi2026-10-25T05:40:46-07:00Ivarmacitinib cho thấy hiệu quả nhanh đầy hứa hẹn và điều hòa miễn dịch trong mụn mủ lòng bàn tay – lòng bàn chân: Góc nhìn từ một thử nghiệm lâm sàng đa trung tâm https://news.medxy.ai/ivarmacitinib-shows-promising-rapid-efficacy-and-immune-modulation-in-palmoplantar-pustulosis-insights-from-a-multicenter-clinical-trial/Medxy AIen2026-10-25T05:40:17-07:00Ivarmacitinib Shows Promising Rapid Efficacy and Immune Modulation in Palmoplantar Pustulosis: Insights from a Multicenter Clinical Trial https://news.medxy.ai/zh/awake-sedation-tap-block-liposuction/Medxy AIzh2026-10-25T05:39:34-07:00清醒镇静联合TAP block与肿胀麻醉在门诊脂肪抽吸联合腹壁整形术中的应用：一种安全有效的镇痛策略 https://news.medxy.ai/ja/pain-management-strategies/Medxy AIja2026-10-25T05:39:06-07:00鎮静・TAPブロック・ツメセント麻酔による日帰りリポアブドミノプラスティー：安全かつ有効な疼痛管理戦略 https://news.medxy.ai/vi/outpatient-abdominoplasty-pain-management/Medxy AIvi2026-10-25T05:38:39-07:00Phẫu thuật tạo hình thành bụng hút mỡ ngoại trú với an thần, TAP block và gây tê tumescent: chiến lược giảm đau an toàn và hiệu quả https://news.medxy.ai/outpatient-lipoabdominoplasty-using-sedation-tap-block-and-tumescent-anesthesia-a-safe-and-effective-pain-management-strategy/Medxy AIen2026-10-25T05:38:18-07:00Outpatient Lipoabdominoplasty Using Sedation, TAP Block, and Tumescent Anesthesia: A Safe and Effective Pain Management Strategy https://news.medxy.ai/zh/tele-icu-transfers/Medxy AIzh2026-10-25T05:37:35-07:00远程重症监护能力与重症 Medicare 患者跨院转运及潜在低价值转运的关联：全国性证据综合 https://news.medxy.ai/ja/remote-critical-care-transfers/Medxy AIja2026-10-25T05:37:05-07:00远程重症监护能力如何影响院际转运？——一项基于全国证据的系统综述 https://news.medxy.ai/vi/tele-icu-transfers-low-value-care/Medxy AIvi2026-10-25T05:36:35-07:00Chăm sóc hồi sức từ xa có liên quan gì đến chuyển viện giữa các bệnh viện và các ca chuyển viện có thể có giá trị thấp ở người bệnh Medicare nguy kịch? Bằng chứng tổng hợp toàn quốc https://news.medxy.ai/association-of-tele-critical-care-capability-with-interhospital-transfers-and-potentially-low-value-transfers-among-critically-ill-medicare-beneficiaries/Medxy AIen2026-10-25T05:36:03-07:00Association of Tele-Critical Care Capability With Interhospital Transfers and Potentially Low-Value Transfers Among Critically Ill Medicare Beneficiaries: A Nationwide Evidence Synthesis https://news.medxy.ai/zh/improving-clinic-care-experience/Medxy AIzh2026-10-25T05:35:08-07:00提升门诊照护体验：患者对环境式 AI 病历记录员的感受 https://news.medxy.ai/ja/ambient-ai-scribes-in-outpatient-care/Medxy AIja2026-10-25T05:34:46-07:00外来診療を支えるアンビエントAIスクライブ：患者はどう体験したか https://news.medxy.ai/enhancing-ambulatory-care-patient-experiences-with-ambient-ai-scribes/Medxy AIen2026-10-25T05:33:55-07:00Enhancing Ambulatory Care: Patient Experiences with Ambient AI Scribes https://news.medxy.ai/zh/midostaurin-venetoclax-aml/Medxy AIzh2026-10-25T05:33:21-07:00老年新诊断AML患者中米哚妥林联合低剂量阿糖胞苷与维奈克拉：INTERVENE II期试验的证据与启示 https://news.medxy.ai/ja/midostaurin-cytarabine-venetoclax-aml/Medxy AIja2026-10-25T05:32:47-07:00高齢の新規診断AMLに対するmidostaurin＋低用量シタラビン＋venetoclax：INTERVENE第2相試験からみたエビデンスと臨床的意義 https://news.medxy.ai/vi/87377-2-87377/Medxy AIvi2026-10-25T05:32:15-07:00Sử dụng midostaurin kết hợp với cytarabine liều thấp và venetoclax ở bệnh nhân cao tuổi mới được chẩn đoán mắc bệnh bạch cầu cấp dòng tủy (AML) https://news.medxy.ai/combining-midostaurin-with-low-dose-cytarabine-and-venetoclax-in-older-adults-with-newly-diagnosed-aml-evidence-and-implications-from-the-intervene-phase-2-trial/Medxy AIen2026-10-25T05:31:41-07:00Combining Midostaurin with Low-Dose Cytarabine and Venetoclax in Older Adults with Newly Diagnosed AML: Evidence and Implications from the INTERVENE Phase 2 Trial https://news.medxy.ai/zh/bronchiectasis-womens-health/Medxy AIzh2026-10-25T05:30:47-07:00支气管扩张症中的生育、妊娠与女性健康：来自多中心研究和全球患者调查的启示 https://news.medxy.ai/ja/bronchiectasis-pregnancy-health/Medxy AIja2026-10-25T05:30:22-07:00気管支拡張症女性の妊孕性・妊娠・健康を考える：多施設研究と国際患者調査からの知見 https://news.medxy.ai/vi/fertility-pregnancy-bronchiectasis/Medxy AIvi2026-10-25T05:29:52-07:00Khả năng sinh sản, thai kỳ và sức khỏe phụ nữ trong giãn phế quản: Góc nhìn từ nghiên cứu đa trung tâm và khảo sát bệnh nhân toàn cầu https://news.medxy.ai/fertility-pregnancy-and-womens-health-in-bronchiectasis-insights-from-a-multicenter-study-and-global-patient-survey/Medxy AIen2026-10-25T05:29:28-07:00Fertility, Pregnancy, and Women’s Health in Bronchiectasis: Insights from a Multicenter Study and Global Patient Survey https://news.medxy.ai/zh/intraocular-lens-power-calculation/Medxy AIzh2026-10-25T05:28:46-07:00超长眼人工晶状体屈光度计算优化：轴长校正与 AL/R 比值的作用 https://news.medxy.ai/vi/intraocular-lens-power-calculation-ar/Medxy AIvi2026-10-25T05:27:44-07:00Tối ưu hóa việc tính toán công suất thủy tinh thể nhân tạo cho mắt có trục nhãn cầu cực dài: Vai trò của việc hiệu chỉnh chiều dài trục nhãn cầu và tỷ số AL/R https://news.medxy.ai/optimizing-intraocular-lens-power-calculations-in-extremely-long-eyes-the-role-of-axial-length-adjustment-and-al-r-ratio/Medxy AIen2026-10-25T05:27:18-07:00Optimizing Intraocular Lens Power Calculations in Extremely Long Eyes: The Role of Axial Length Adjustment and AL/R Ratio https://news.medxy.ai/zh/idiopathic-unilateral-vestibulopathy/Medxy AIzh2026-10-25T05:26:36-07:00特发性急性单侧听前庭病的神经耳科与3D-FLAIR MRI相关性：推动诊断与机制认识 https://news.medxy.ai/ja/neurotologic-findings-and-mriorrelation/Medxy AIja2026-10-25T05:26:11-07:00特発性急性片側性聴前庭障害における神経耳科学的所見と3D-FLAIR MRIの関連：診断精度と病態理解の向上 https://news.medxy.ai/vi/idiopathic-unilateral-acute-vestibulopathy-mri/Medxy AIvi2026-10-25T05:25:34-07:00MRI 3D-FLAIR và dấu ấn thính thần kinh trong thính tiền đình cấp một bên vô căn: mở rộng chẩn đoán và hiểu biết https://news.medxy.ai/neurotologic-and-3d-flair-mri-correlates-in-idiopathic-acute-unilateral-audiovestibulopathy-advancing-diagnosis-and-understanding/Medxy AIen2026-10-25T05:25:10-07:00Neurotologic and 3D-FLAIR MRI Correlates in Idiopathic Acute Unilateral Audiovestibulopathy: Advancing Diagnosis and Understanding https://news.medxy.ai/zh/mesh-placement-matters/Medxy AIzh2026-10-25T05:24:28-07:00补片放置位置很关键：丹麦全国队列中择期切口疝修补术后的患者报告结局 https://news.medxy.ai/ja/postoperative-sensation-mesh-location/Medxy AIja2026-10-25T05:23:58-07:00メッシュの位置で変わる術後感覚：デンマーク全国コホートが示した切開ヘルニア修復後の患者報告アウトカム https://news.medxy.ai/vi/mesh-position-outcomes-incinerate/Medxy AIvi2026-10-25T05:23:26-07:00Vị trí đặt lưới có ý nghĩa: Kết cục do bệnh nhân báo cáo sau phẫu thuật sửa chữa thoát vị vết mổ theo kế hoạch trong một đoàn hệ toàn quốc tại Đan Mạch https://news.medxy.ai/mesh-position-matters-patient-reported-outcomes-after-elective-incisional-hernia-repair-in-a-danish-nationwide-cohort/Medxy AIen2026-10-25T05:22:59-07:00Mesh Position Matters: Patient-Reported Outcomes After Elective Incisional Hernia Repair in a Danish Nationwide Cohort https://news.medxy.ai/ja/maternal-choline-child-development/Medxy AIja2026-10-25T05:22:13-07:00妊娠中の母体ホスファチジルコリンと4歳までの児の行動・認知：ランダム化臨床試験 https://news.medxy.ai/vi/maternal-phosphatidylcholine-pregnancy-child-development/Medxy AIvi2026-10-25T05:21:32-07:00Phosphatidylcholine của mẹ trong thai kỳ và hành vi, nhận thức của trẻ đến 4 tuổi: Thử nghiệm lâm sàng ngẫu nhiên https://news.medxy.ai/prenatal-maternal-phosphatidylcholine-and-childrens-behavior-and-cognition-through-4-years-of-age-randomized-clinical-trial/Medxy AIen2026-10-25T05:21:02-07:00Prenatal Maternal Phosphatidylcholine and Children’s Behavior and Cognition through 4 Years of Age: Randomized Clinical Trial https://news.medxy.ai/zh/vascular-risk-factors-epilepsy/Medxy AIzh2026-10-25T05:20:15-07:00血管危险因素或是晚发性癫痫的重要推手：基于美国大型队列荟萃分析的新证据 https://news.medxy.ai/ja/vascular-risk-factors-late-onset-epilepsy/Medxy AIja2026-10-25T05:19:50-07:00血管性危険因子は晩発性てんかんの主要因か――米国大規模コホート統合解析から見えたこと https://news.medxy.ai/vi/vascular-risk-factors-2/Medxy AIvi2026-10-25T05:19:14-07:00Yếu tố nguy cơ mạch máu: tác nhân then chốt thúc đẩy động kinh khởi phát muộn trong một phân tích gộp quy mô lớn tại Hoa Kỳ https://news.medxy.ai/vascular-risk-factors-as-key-contributors-to-late-onset-epilepsy-insights-from-a-large-us-cohort-meta-analysis/Medxy AIen2026-10-25T05:18:47-07:00Vascular Risk Factors as Key Contributors to Late-Onset Epilepsy: Insights from a Large US Cohort Meta-Analysis https://news.medxy.ai/zh/setmelanotide-metabolic-risk/Medxy AIzh2026-10-25T05:17:59-07:00Setmelanotide 治疗可降低 POMC 或 LEPR 缺陷患者的代谢综合征风险 https://news.medxy.ai/ja/setmelanotide-reduces-metabolic-risk/Medxy AIja2026-10-25T05:17:33-07:00setmelanotide治療、POMC／LEPR欠損症患者のメタボリックシンドロームリスクを低減 https://news.medxy.ai/vi/setmelanotide-metabolic-syndrome-risk/Medxy AIvi2026-10-25T05:17:03-07:00Setmelanotide giúp giảm nguy cơ hội chứng chuyển hóa ở bệnh nhân thiếu hụt POMC hoặc LEPR https://news.medxy.ai/setmelanotide-therapy-reduces-metabolic-syndrome-risk-in-patients-with-pomc-or-lepr-deficiencies/Medxy AIen2026-10-25T05:16:40-07:00Setmelanotide Therapy Reduces Metabolic Syndrome Risk in Patients with POMC or LEPR Deficiencies https://news.medxy.ai/zh/sst2-fulminant-myocarditis-mechanism/Medxy AIzh2026-10-25T05:15:59-07:00揭示 sST2 在暴发性心肌炎中的致病作用：一种新的线粒体治疗轴 https://news.medxy.ai/sst2-myocarditis-treatment/Medxy AIen2026-10-25T05:14:27-07:00Unraveling sST2’s Role in Fulminant Myocarditis: A Novel Mitochondrial Therapeutic Axis https://news.medxy.ai/zh/early-quadriceps-strength-recovery-predicts-2-year-outcomes/Medxy AIzh2026-10-25T05:13:39-07:00采用自体股四头肌腱移植进行前交叉韧带重建术后，股四头肌肌力的早期恢复可预测术后2年的预后结果 https://news.medxy.ai/ja/early-quadriceps-strength-recovery-predicts-outcomes-after-quadriceps-tendon-autograft-acl-reconstruction/Medxy AIja2026-10-25T05:13:10-07:00自家大腿四頭筋腱を用いたACL再建術後2年における転帰の予測因子としての、大腿四頭筋筋力の早期回復 https://news.medxy.ai/vi/early-quadriceps-strength-predicts-acl-outcomes/Medxy AIvi2026-10-25T05:12:33-07:00Phục hồi sớm sức mạnh cơ tứ đầu đùi dự báo kết cục sau 2 năm sau tái tạo ACL bằng mảnh ghép tự thân gân cơ tứ đầu đùi https://news.medxy.ai/early-quadriceps-strength-recovery-predicts-2-year-outcomes-after-quadriceps-tendon-autograft-acl-reconstruction/Medxy AIen2026-10-25T05:12:00-07:00Early Quadriceps Strength Recovery Predicts 2-Year Outcomes After Quadriceps Tendon Autograft ACL Reconstruction https://news.medxy.ai/vi/soft-tissue-augmentation-dental-implants/Medxy AIvi2026-10-25T05:11:55-07:00Đánh giá tăng cường mô mềm trong cấy ghép nha khoa thẩm mỹ: Ghép mô liên kết hay màng collagen ổn định thể tích https://news.medxy.ai/zh/soft-tissue-augmentation-choices/Medxy AIzh2026-10-25T05:11:02-07:00美学种植中的软组织增量如何选择：结缔组织移植与稳定体积胶原基质的比较 https://news.medxy.ai/ja/soft-tissue-augmentation-in-implant-treatment/Medxy AIja2026-10-25T05:10:38-07:00審美的インプラント治療における軟組織増大の評価：結合組織移植片と厚み安定性コラーゲンマトリックスの比較 https://news.medxy.ai/ja/balance-and-dizziness-improvement/Medxy AIja2026-10-25T05:10:35-07:00慢性末梢性前庭機能障害におけるバランス改善とめまい軽減：反復経頭蓋磁気刺激の役割 https://news.medxy.ai/enhancing-balance-and-reducing-dizziness-in-chronic-peripheral-vestibular-dysfunction-the-role-of-repetitive-transcranial-magnetic-stimulation/Medxy AIen2026-10-25T05:09:51-07:00Enhancing Balance and Reducing Dizziness in Chronic Peripheral Vestibular Dysfunction: The Role of Repetitive Transcranial Magnetic Stimulation https://news.medxy.ai/evaluating-soft-tissue-augmentation-in-aesthetic-implant-dentistry-connective-tissue-graft-versus-volume-stable-collagen-matrix/Medxy AIen2026-10-25T05:09:30-07:00Evaluating Soft-Tissue Augmentation in Aesthetic Implant Dentistry: Connective Tissue Graft Versus Volume-Stable Collagen Matrix https://news.medxy.ai/zh/repetitive-magnetic-stimulation-for-vertigo/Medxy AIzh2026-10-25T05:09:06-07:00慢性外周前庭功能障碍的平衡改善与眩晕减轻：经颅重复磁刺激的作用 https://news.medxy.ai/zh/acute-kidney-replacement-therapy/Medxy AIzh2026-10-25T05:08:42-07:00急性肾损伤中间歇性与连续肾脏替代治疗：来自多中心试验的启示 https://news.medxy.ai/ja/intermittent-vs-continuous-dialysis/Medxy AIja2026-10-25T05:08:17-07:00急性腎障害における間欠的治療と持続的腎代替療法：多施設試験から見えたもの https://news.medxy.ai/vi/intermittent-vs-continuous-dialysis-2/Medxy AIvi2026-10-25T05:07:45-07:00Thay thế thận ngắt quãng hay liên tục trong tổn thương thận cấp: Những phát hiện từ một thử nghiệm đa trung tâm https://news.medxy.ai/intermittent-vs-continuous-renal-replacement-therapy-in-acute-kidney-injury-insights-from-a-multicenter-trial/Medxy AIen2026-10-25T05:07:20-07:00Intermittent vs Continuous Renal-Replacement Therapy in Acute Kidney Injury: Insights from a Multicenter Trial https://news.medxy.ai/zh/digoxin-discontinuation-heart-failure/Medxy AIzh2026-10-24T04:07:54-07:00停用地高辛对心力衰竭的临床影响：DECISION 试验带来的启示 https://news.medxy.ai/ja/clinical-impact-of-digoxin-discontinuation/Medxy AIja2026-10-24T04:07:30-07:00心不全におけるジゴキシン中止の臨床的影響：DECISION試験から得られた知見 https://news.medxy.ai/vi/digoxin-discontinuation-heart-failure-2/Medxy AIvi2026-10-24T04:07:02-07:00Tác động lâm sàng của việc ngừng Digoxin trong suy tim: Những phát hiện từ thử nghiệm DECISION https://news.medxy.ai/clinical-impact-of-digoxin-withdrawal-in-heart-failure-insights-from-the-decision-trial/Medxy AIen2026-10-24T04:06:39-07:00Clinical Impact of Digoxin Withdrawal in Heart Failure: Insights from the DECISION Trial https://news.medxy.ai/zh/psychological-readiness-sports-in-adolescents/Medxy AIzh2026-10-24T04:05:53-07:00青少年髌骨稳定术后成功重返运动的预测因素：心理准备度 https://news.medxy.ai/ja/psychological-readiness-as-successful-return-to-sports-in-adolescents/Medxy AIja2026-10-24T04:05:17-07:00膝蓋骨安定化術を受けた青年における、スポーツ復帰の成功を予測する指標としての心理的準備状態 https://news.medxy.ai/vi/psychological-readiness-predicts-return-sport/Medxy AIvi2026-10-24T04:04:47-07:00Mức độ sẵn sàng tâm lý có dự đoán thành công trở lại thể thao ở thanh thiếu niên sau phẫu thuật ổn định xương bánh chè hay không? https://news.medxy.ai/psychological-readiness-as-a-predictor-of-successful-return-to-sports-in-adolescents-after-patellar-stabilization-surgery/Medxy AIen2026-10-24T04:04:24-07:00Psychological Readiness as a Predictor of Successful Return to Sports in Adolescents After Patellar Stabilization Surgery https://news.medxy.ai/zh/aquatic-training-patellofemoral-pain/Medxy AIzh2026-10-24T04:03:38-07:00水中增强式训练：青少年髌股疼痛综合征管理的新突破 https://news.medxy.ai/ja/aquatic-plyometrics-knee-pain-strategy/Medxy AIja2026-10-24T04:03:21-07:00水中プライオメトリクスが切り拓く、思春期膝蓋大腿疼痛症候群の新たな治療戦略 https://news.medxy.ai/vi/underwater-plyometrics-knee-pain/Medxy AIvi2026-10-24T04:02:56-07:00Plyometrics dưới nước: Bước tiến mới trong điều trị hội chứng đau khớp bánh chè-đùi ở thanh thiếu niên https://news.medxy.ai/aquatic-plyometrics-a-breakthrough-in-managing-adolescent-patellofemoral-pain-syndrome/Medxy AIen2026-10-24T04:02:34-07:00Aquatic Plyometrics: A Breakthrough in Managing Adolescent Patellofemoral Pain Syndrome https://news.medxy.ai/zh/ai-panoramic-xray-scoring-disease-links/Medxy AIzh2026-10-24T04:01:43-07:00AI生成全景X线片评分揭示口腔健康与多种重大全身性疾病的关联 https://news.medxy.ai/ja/oral-health-ai-insights/Medxy AIja2026-10-24T04:01:15-07:00AIで見える口腔の健康と全身疾患の関連：パノラマX線スコアの新たな可能性 https://news.medxy.ai/vi/ai-generated-x-ray-scores/Medxy AIvi2026-10-24T04:00:46-07:00Điểm số phim X-quang toàn cảnh do AI tạo ra: Cầu nối giữa sức khỏe răng miệng và các bệnh lý toàn thân lớn https://news.medxy.ai/ai-derived-panoramic-radiograph-score-links-oral-health-to-major-systemic-diseases/Medxy AIen2026-10-24T04:00:24-07:00AI-Derived Panoramic Radiograph Score Links Oral Health to Major Systemic Diseases https://news.medxy.ai/zh/garetosmab-fop-disease-modifier/Medxy AIzh2026-10-24T03:59:38-07:00Garetosmab：进行性骨化性纤维发育不良的潜在疾病修饰抗体 https://news.medxy.ai/ja/garetosmab-fop-antibody/Medxy AIja2026-10-24T03:59:17-07:00Garetosmab、FOP に対する有望な疾患修飾抗体 https://news.medxy.ai/vi/garetosmab-promising-treatment-fop/Medxy AIvi2026-10-24T03:58:54-07:00Garetosmab: Kháng thể điều biến bệnh đầy hứa hẹn cho fibrodysplasia ossificans progressiva https://news.medxy.ai/garetosmab-a-promising-disease-modifying-antibody-for-fibrodysplasia-ossificans-progressiva/Medxy AIen2026-10-24T03:58:33-07:00Garetosmab: A Promising Disease-Modifying Antibody for Fibrodysplasia Ossificans Progressiva https://news.medxy.ai/ja/adolescent-oral-hygiene/Medxy AIja2026-10-24T03:57:43-07:00思春期の口腔衛生を見直す：2026年AAP臨床報告の重要ポイント https://news.medxy.ai/vi/adolescent-oral-health-recommendations/Medxy AIvi2026-10-24T03:56:48-07:00Sức khỏe răng miệng ở thanh thiếu niên: Các khuyến nghị cốt lõi từ Báo cáo lâm sàng AAP 2026 https://news.medxy.ai/zh/teen-dental-health-recommendations/Medxy AIzh2026-10-24T03:55:58-07:00青少年口腔健康：2026年AAP临床报告的关键建议 https://news.medxy.ai/oral-health-for-adolescents-key-recommendations-from-the-2026-aap-clinical-report/Medxy AIen2026-10-24T03:55:18-07:00Oral Health for Adolescents: Key Recommendations from the 2026 AAP Clinical Report https://news.medxy.ai/zh/early-synovial-lipid-dysregulation/Medxy AIzh2026-10-24T03:53:57-07:00滑膜成纤维细胞脂质代谢的早期异常：窥见类风湿关节炎发病机制的一扇窗口 https://news.medxy.ai/ja/lipid-metabolic-alterations-in-synovial-fibroblasts/Medxy AIja2026-10-24T03:53:32-07:00滑膜線維芽細胞における脂質代謝の早期異常：関節リウマチの病態メカニズムを解明する窓口 https://news.medxy.ai/vi/early-lipid-metabolic-alterations-in-synovial-fibroblasts/Medxy AIvi2026-10-24T03:53:06-07:00Những bất thường sớm trong quá trình chuyển hóa lipid ở các nguyên bào sợi màng hoạt dịch: Góc nhìn về cơ chế bệnh sinh của viêm khớp dạng thấp https://news.medxy.ai/early-lipid-metabolic-alterations-in-synovial-fibroblasts-a-window-into-rheumatoid-arthritis-pathogenesis/Medxy AIen2026-10-24T03:52:44-07:00Early Lipid Metabolic Alterations in Synovial Fibroblasts: A Window into Rheumatoid Arthritis Pathogenesis https://news.medxy.ai/zh/global-liver-transplant-disparities/Medxy AIzh2026-10-24T03:52:05-07:00跨越鸿沟：全球肝移植差异与疾病负担的失衡（2000—2023） https://news.medxy.ai/ja/global-liver-transplant-disparities-2/Medxy AIja2026-10-24T03:51:41-07:00肝移植と疾患負担の世界的不均衡：2000～2023年の格差を可視化する https://news.medxy.ai/vi/liver-transplant-disparities/Medxy AIvi2026-10-24T03:51:12-07:00Thu hẹp khoảng cách: Chênh lệch toàn cầu trong ghép gan và gánh nặng bệnh tật (2000–2023) https://news.medxy.ai/bridging-the-gap-global-disparities-in-liver-transplantation-and-disease-burden-2000-2023/Medxy AIen2026-10-24T03:50:50-07:00Bridging the Gap: Global Disparities in Liver Transplantation and Disease Burden (2000-2023) https://news.medxy.ai/zh/litifilimab-lupus-treatment/Medxy AIzh2026-10-24T03:50:08-07:00Litifilimab在皮肤型红斑狼疮治疗中显示出良好疗效与安全性：AMETHYST Ⅱ期试验带来新启示 https://news.medxy.ai/ja/litifilimab-for-cutaneous-lupus/Medxy AIja2026-10-24T03:49:46-07:00皮膚エリテマトーデスに対するlitifilimabの有望性：AMETHYST第2相試験からみた有効性と安全性 https://news.medxy.ai/vi/litifilimab-lupus-trial/Medxy AIvi2026-10-24T03:49:21-07:00Litifilimab cho thấy hiệu quả và độ an toàn đầy hứa hẹn trong điều trị lupus ban đỏ da: Góc nhìn từ thử nghiệm AMETHYST pha 2 https://news.medxy.ai/litifilimab-shows-promising-efficacy-and-safety-in-treating-cutaneous-lupus-erythematosus-insights-from-the-amethyst-phase-2-trial/Medxy AIen2026-10-24T03:49:02-07:00Litifilimab Shows Promising Efficacy and Safety in Treating Cutaneous Lupus Erythematosus: Insights from the AMETHYST Phase 2 Trial https://news.medxy.ai/zh/ultrasound-lymphatic-venous-anastomosis/Medxy AIzh2026-10-24T03:48:19-07:00超声用于淋巴水肿手术中淋巴静脉吻合部位定位：诊断准确性及临床意义 https://news.medxy.ai/ja/ultrasound-lymphatic-venous-anastomosis-surgery-diagnostic-accuracy/Medxy AIja2026-10-24T03:47:54-07:00リンパ浮腫手術におけるリンパ管静脈吻合部位の超音波による特定：診断精度および臨床的意義 https://news.medxy.ai/vi/ultrasound-lymphatic-surgery/Medxy AIvi2026-10-24T03:47:26-07:00Siêu âm: công cụ đáng tin cậy để định vị vị trí nối bạch huyết-tĩnh mạch trong phẫu thuật phù bạch huyết https://news.medxy.ai/ultrasound-as-a-reliable-tool-for-localizing-lymphovenous-anastomosis-sites-in-lymphedema-surgery-diagnostic-accuracy-and-clinical-implications/Medxy AIen2026-10-24T03:47:04-07:00Ultrasound as a Reliable Tool for Localizing Lymphovenous Anastomosis Sites in Lymphedema Surgery: Diagnostic Accuracy and Clinical Implications https://news.medxy.ai/zh/icu-infection-risk/Medxy AIzh2026-10-24T03:46:22-07:00巴西大型队列揭示：血液系统肿瘤及免疫抑制癌症患者 ICU 获得性感染风险显著升高 https://news.medxy.ai/ja/icu-acquired-infections/Medxy AIja2026-10-24T03:45:57-07:00血液腫瘍・免疫抑制があるがん患者ではICU獲得感染症リスクが上昇：ブラジル大規模コホートからの示唆 https://news.medxy.ai/vi/icu-infection-risk-2/Medxy AIvi2026-10-24T03:45:30-07:00Nguy cơ nhiễm trùng mắc phải tại ICU tăng ở bệnh nhân ung thư huyết học và suy giảm miễn dịch: Bằng chứng từ một đoàn hệ lớn tại Brazil https://news.medxy.ai/heightened-risk-of-icu-acquired-infections-in-hematological-and-immunosuppressed-cancer-patients-insights-from-a-large-brazilian-cohort/Medxy AIen2026-10-24T03:45:07-07:00Heightened Risk of ICU-Acquired Infections in Hematological and Immunosuppressed Cancer Patients: Insights from a Large Brazilian Cohort https://news.medxy.ai/zh/racial-disparities-antibiotics/Medxy AIzh2026-10-24T03:44:26-07:00呼吸道感染诊断与抗生素处方中的种族差异：为何非白人患者更少获得抗生素？ https://news.medxy.ai/ja/racial-disparities-in-respiratory-infections/Medxy AIja2026-10-24T03:44:04-07:00呼吸器感染症診断と抗菌薬処方にみられる人種差を読み解く https://news.medxy.ai/vi/racial-disparities-antibiotic-prescribing/Medxy AIvi2026-10-24T03:43:40-07:00Làm sáng tỏ chênh lệch chủng tộc trong chẩn đoán nhiễm trùng đường hô hấp và mô hình kê kháng sinh https://news.medxy.ai/unraveling-racial-disparities-in-respiratory-tract-infection-diagnoses-and-antibiotic-prescribing-patterns/Medxy AIen2026-10-24T03:43:19-07:00Unraveling Racial Disparities in Respiratory Tract Infection Diagnoses and Antibiotic Prescribing Patterns https://news.medxy.ai/zh/immunoglobulin-targeted-immunotherapy/Medxy AIzh2026-10-24T03:42:35-07:00靶向免疫球蛋白恒定区：一种用于多发性骨髓瘤的新型 T 细胞受体免疫治疗 https://news.medxy.ai/ja/novel-tcr-immunotherapy-immune-globulin-recurrence/Medxy AIja2026-10-24T03:42:02-07:00免疫グロブリン定常領域を狙う新規TCRベース免疫療法：多発性骨髄腫への応用 https://news.medxy.ai/vi/novel-tcr-immunotherapy-immune-globulin-recurrence-in-mm/Medxy AIvi2026-10-24T03:41:33-07:00Nhắm vào vùng hằng định của immunoglobulin: Một liệu pháp miễn dịch dựa trên thụ thể tế bào T đầy mới mẻ dành cho bệnh đa u tủy https://news.medxy.ai/targeting-immunoglobulin-constant-domains-a-novel-t-cell-receptor-based-immunotherapy-for-multiple-myeloma/Medxy AIen2026-10-24T03:41:10-07:00Targeting Immunoglobulin Constant Domains: A Novel T-Cell Receptor-Based Immunotherapy for Multiple Myeloma https://news.medxy.ai/zh/clarithromycin-immunomodulation-pneumonia/Medxy AIzh2026-10-24T03:40:28-07:00克拉霉素在社区获得性肺炎中的免疫调节作用：来自 ACCESS 试验炎症蛋白组分析的启示 https://news.medxy.ai/ja/clarithromycin-immunomodulation-pneumonia-3/Medxy AIja2026-10-24T03:40:07-07:00市中肺炎におけるクラリスロマイシンの免疫調節作用：ACCESS試験の炎症性プロテオーム解析が示す知見 https://news.medxy.ai/vi/clarithromycin-immunomodulation-pneumonia-2/Medxy AIvi2026-10-24T03:39:43-07:00Tác động điều hòa miễn dịch của clarithromycin trong viêm phổi mắc phải cộng đồng: Những phát hiện từ phân tích proteome viêm của thử nghiệm ACCESS https://news.medxy.ai/immunomodulatory-effects-of-clarithromycin-in-community-acquired-pneumonia-insights-from-the-access-trials-inflammatory-proteome-analysis/Medxy AIen2026-10-24T03:39:22-07:00Immunomodulatory Effects of Clarithromycin in Community-Acquired Pneumonia: Insights from the ACCESS Trial’s Inflammatory Proteome Analysis https://news.medxy.ai/zh/charlson-index-vision-outcomes/Medxy AIzh2026-10-24T03:38:36-07:00Charlson合并症指数能否预测视网膜静脉阻塞相关黄斑水肿的视力结局？——一项长达十年的队列研究揭示 https://news.medxy.ai/ja/charlson-index-vision-outcomesvisual-outcomes-in-retinal-vein-occlusion-related-macular-edema/Medxy AIja2026-10-24T03:38:15-07:00チャールソン併存疾患指数は、網膜静脈閉塞症に伴う黄斑浮腫の視力予後を予測できるか？――10年にわたるコホート研究が明らかに https://news.medxy.ai/vi/charlson-index-vision-outcomesvisual-outcomes-in-retinal-vein-occlusion/Medxy AIvi2026-10-24T03:37:54-07:00Chỉ số bệnh lý đi kèm Charlson có thể dự đoán kết quả thị lực trong trường hợp phù hoàng điểm do tắc tĩnh mạch võng mạc hay không? — Những góc nhìn từ một nghiên cứu đoàn hệ kéo dài mười năm https://news.medxy.ai/charlson-comorbidity-index-as-a-predictor-of-visual-outcomes-in-retinal-vein-occlusion-related-macular-edema-insights-from-a-decade-long-cohort-study/Medxy AIen2026-10-24T03:37:34-07:00Charlson Comorbidity Index as a Predictor of Visual Outcomes in Retinal Vein Occlusion-Related Macular Edema: Insights from a Decade-Long Cohort Study https://news.medxy.ai/zh/patient-communication-rhinoplasty/Medxy AIzh2026-10-24T03:36:49-07:00鼻中隔鼻整形术中患者主动沟通：发生率、主题与预测因素 https://news.medxy.ai/ja/patient-led-communication-in-septorhinoplasty/Medxy AIja2026-10-24T03:36:28-07:00Septorhinoplastyにおける患者主導コミュニケーションを読み解く：発生頻度、主題、予測因子 https://news.medxy.ai/vi/patient-initiated-communication-septorhinoplasty/Medxy AIvi2026-10-24T03:36:06-07:00Giao tiếp do người bệnh chủ động trong septorhinoplasty: Tỷ lệ, chủ đề và các yếu tố dự báo https://news.medxy.ai/understanding-patient-initiated-communication-in-septorhinoplasty-prevalence-themes-and-predictors/Medxy AIen2026-10-24T03:35:46-07:00Understanding Patient-Initiated Communication in Septorhinoplasty: Prevalence, Themes, and Predictors https://news.medxy.ai/zh/pregnancy-cardiomyopathy-outcomes/Medxy AIzh2026-10-24T03:34:59-07:00既往心肌病女性妊娠结局：来自英国前瞻性队列研究的启示 https://news.medxy.ai/ja/pregnancy-cardiomyopathy-outcomes-2/Medxy AIja2026-10-24T03:34:39-07:00既存心筋症を有する女性の妊娠転帰：英国前向きコホート研究からみた知見 https://news.medxy.ai/vi/pregnancy-outcomes-cardiomyopathy/Medxy AIvi2026-10-24T03:34:19-07:00Kết cục thai kỳ ở phụ nữ có bệnh cơ tim từ trước: Góc nhìn từ một nghiên cứu đoàn hệ tiền cứu tại Vương quốc Anh https://news.medxy.ai/pregnancy-outcomes-in-women-with-preexisting-cardiomyopathy-insights-from-a-uk-prospective-cohort-study/Medxy AIen2026-10-24T03:33:57-07:00Pregnancy Outcomes in Women with Preexisting Cardiomyopathy: Insights from a UK Prospective Cohort Study https://news.medxy.ai/zh/apoe-alleles-cognitive-trajectories/Medxy AIzh2026-10-24T03:33:14-07:00APOE ɛ4与ɛ2等位基因如何影响九旬以上人群的认知轨迹：来自LifeAfter90研究的启示 https://news.medxy.ai/bridging-the-gap-addressing-low-breast-cancer-screening-rates-among-resident-physicians-in-academic-primary-care/Medxy AIen2026-10-24T03:32:53-07:00Bridging the Gap: Addressing Low Breast Cancer Screening Rates Among Resident Physicians in Academic Primary Care https://news.medxy.ai/ja/apoe-alleles-cognition-90-plus/Medxy AIja2026-10-24T03:32:50-07:0090歳以上の認知機能に対するAPOE ɛ4・ɛ2アレルの影響――LifeAfter90研究が示す知見 https://news.medxy.ai/cases-of-high-titer-inhibitor-formation-after-aav-gene-therapy-for-hemophilia-a/Medxy AIen2026-10-24T03:32:17-07:00Cases of High-Titer Inhibitor Formation After AAV Gene Therapy for Hemophilia A https://news.medxy.ai/vi/apoe-cognitive-trajectories-90-plus/Medxy AIvi2026-10-24T03:32:14-07:00APOE ɛ4 và ɛ2 ảnh hưởng thế nào đến quỹ đạo nhận thức ở người từ 90 tuổi trở lên? Kết quả từ nghiên cứu LifeAfter90 https://news.medxy.ai/quantitative-computed-tomography-in-progressive-pulmonary-fibrosis-insights-from-the-inbuild-trial-sub-study/Medxy AIen2026-10-24T03:31:01-07:00Quantitative Computed Tomography in Progressive Pulmonary Fibrosis: Insights from the INBUILD Trial Sub-Study https://news.medxy.ai/zh/racial-heart-risk-disparities/Medxy AIzh2026-10-24T03:31:00-07:00PMOS 女性心血管风险的种族差异及社会决定因素：黑人女性受影响最明显 https://news.medxy.ai/ja/pmos-racial-heart-risk-disparities/Medxy AIja2026-10-24T03:30:39-07:00PMOS：女性の心血管疾患リスクにおける人種差と社会的決定要因――黒人女性への影響が最も顕著 https://news.medxy.ai/vi/pmos-racial-heart-risk-in-women/Medxy AIvi2026-10-24T03:30:17-07:00Sự chênh lệch chủng tộc và các yếu tố xã hội quyết định nguy cơ tim mạch ở phụ nữ: Phụ nữ da đen là nhóm chịu ảnh hưởng nghiêm trọng nhất https://news.medxy.ai/racial-disparities-and-social-determinants-in-cardiovascular-risk-among-women-with-polyendocrine-metabolic-ovarian-syndrome/Medxy AIen2026-10-24T03:29:56-07:00Racial Disparities and Social Determinants in Cardiovascular Risk Among Women with Polyendocrine Metabolic Ovarian Syndrome https://news.medxy.ai/zh/icare-faster-trial/Medxy AIzh2026-10-24T03:29:12-07:00ICare-FASTER 试验：床旁高敏肌钙蛋白检测推动急诊护理革新 https://news.medxy.ai/vi/icare-faster-troponin-testing/Medxy AIvi2026-10-24T03:28:19-07:00ICare-FASTER: Bước tiến mới trong cấp cứu với xét nghiệm troponin độ nhạy cao tại giường bệnh https://news.medxy.ai/zh/labral-tears-cartilage-loss/Medxy AIzh2026-10-24T03:27:12-07:00年轻高冲击运动员的盂唇撕裂与软骨丢失：来自FORCe纵向研究的启示 https://news.medxy.ai/ja/labral-tears-cartilage-loss-2/Medxy AIja2026-10-24T03:26:48-07:00若年高強度アスリートにおけるラブラム断裂と軟骨喪失：FORCe縦断研究からの知見 https://news.medxy.ai/vi/labral-tear-cartilage-loss-athletes/Medxy AIvi2026-10-24T03:26:17-07:00Rách sụn viền và mất sụn ở vận động viên trẻ tham gia môn thể thao va chạm mạnh: phát hiện từ nghiên cứu dọc FORCe https://news.medxy.ai/labral-tears-and-cartilage-loss-in-young-high-impact-athletes-insights-from-the-force-longitudinal-study/Medxy AIen2026-10-24T03:25:52-07:00Labral Tears and Cartilage Loss in Young High-Impact Athletes: Insights from the FORCe Longitudinal Study https://news.medxy.ai/zh/ultrasound-guided-prolotherapy-bursitis/Medxy AIzh2026-10-24T03:25:08-07:00超声引导下单次葡萄糖增生疗法联合运动治疗肩峰下-三角肌下滑囊炎：来自先导性双盲随机对照试验的启示 https://news.medxy.ai/ja/ultrasound-guided-prolotherapy-shoulder-bursitis/Medxy AIja2026-10-24T03:24:43-07:00肩峰下‐三角筋下滑液包炎に対する超音波ガイド下デキストロース・プロロセラピー1回投与と運動療法の併用効果：パイロット二重盲検RCTからの知見 https://news.medxy.ai/vi/ultrasound-prolotherapy-shoulder-bursitis/Medxy AIvi2026-10-24T03:24:02-07:00Liệu pháp tăng sinh bằng dextrose thực hiện trong một lần duy nhất dưới hướng dẫn của siêu âm, kết hợp với liệu pháp vận động, dành cho tình trạng viêm túi thanh mạc dưới mỏm cùng vai – dưới cơ delta https://news.medxy.ai/evaluating-single-ultrasound-guided-dextrose-prolotherapy-combined-with-exercise-in-subacromial-subdeltoid-bursitis-insights-from-a-pilot-double-blind-rct/Medxy AIen2026-10-24T03:23:40-07:00Evaluating Single Ultrasound-Guided Dextrose Prolotherapy Combined with Exercise in Subacromial-Subdeltoid Bursitis: Insights from a Pilot Double-Blind RCT https://news.medxy.ai/zh/peri-implantitis-treatment-prediction/Medxy AIzh2026-10-24T03:22:56-07:00微生物网络解析揭示种植体周围炎治疗成功预测信号：一项为期 1 年的纵向研究 https://news.medxy.ai/ja/microbial-network-analysis/Medxy AIja2026-10-24T03:22:35-07:00微生物ネットワーク解析が予測するインプラント周囲炎治療成功：1年間縦断研究 https://news.medxy.ai/vi/microbiome-predicts-implant-treatment-success/Medxy AIvi2026-10-24T03:22:08-07:00Mạng vi sinh vật hé lộ yếu tố dự báo thành công điều trị viêm quanh implant: Nghiên cứu theo dõi dọc 1 năm https://news.medxy.ai/microbial-network-insights-predict-peri-implantitis-therapy-success-a-one-year-longitudinal-study/Medxy AIen2026-10-24T03:21:45-07:00Microbial Network Insights Predict Peri-Implantitis Therapy Success: A One-Year Longitudinal Study https://news.medxy.ai/zh/continuous-glucose-monitoring-3/Medxy AIzh2026-10-24T03:21:01-07:00持续葡萄糖监测助力未用胰岛素2型糖尿病血糖管理：CONNECT试验带来新证据 https://news.medxy.ai/ja/continuous-glucose-monitoring-2/Medxy AIja2026-10-24T03:20:37-07:00インスリン未使用の2型糖尿病における血糖管理を高める連続血糖モニタリング：CONNECT試験の新たなエビデンス https://news.medxy.ai/vi/cgm-improves-glucose-control/Medxy AIvi2026-10-24T03:20:13-07:00CGM giúp cải thiện kiểm soát đường huyết ở đái tháo đường type 2 không dùng insulin: bằng chứng mới từ thử nghiệm CONNECT https://news.medxy.ai/enhancing-glycemic-control-in-non-insulin-treated-type-2-diabetes-with-continuous-glucose-monitoring-new-evidence-from-the-connect-trial/Medxy AIen2026-10-24T03:19:53-07:00Enhancing Glycemic Control in Non-Insulin-Treated Type 2 Diabetes with Continuous Glucose Monitoring: New Evidence from the CONNECT Trial https://news.medxy.ai/zh/lonvoguran-crispr-breakthrough/Medxy AIzh2026-10-24T02:58:35-07:00Lonvoguran Ziclumeran：遗传性血管性水肿的体内 CRISPR 基因编辑疗法取得突破 https://news.medxy.ai/ja/innovative-crispr-gene-therapy/Medxy AIja2026-10-24T02:58:13-07:00遺伝性血管性浮腫に挑む革新的 in vivo CRISPR 遺伝子編集療法：Lonvoguran Ziclumeran https://news.medxy.ai/vi/lonvoguran-ziclumeran-crispr-gene-editing/Medxy AIvi2026-10-24T02:57:46-07:00Lonvoguran Ziclumeran: Bước đột phá liệu pháp chỉnh sửa gen CRISPR in vivo cho phù mạch di truyền https://news.medxy.ai/lonvoguran-ziclumeran-a-breakthrough-in-vivo-crispr-gene-editing-therapy-for-hereditary-angioedema/Medxy AIen2026-10-24T02:57:26-07:00Lonvoguran Ziclumeran: A Breakthrough In Vivo CRISPR Gene-Editing Therapy for Hereditary Angioedema